F Holleman

Summary

Country: The Netherlands

Publications

  1. ncbi Reduced frequency of severe hypoglycemia and coma in well-controlled IDDM patients treated with insulin lispro. The Benelux-UK Insulin Lispro Study Group
    F Holleman
    Department of Internal Medicine, Diakonessenhuis, Utrecht, The Netherlands
    Diabetes Care 20:1827-32. 1997
  2. ncbi Efficacy and safety of two 5 day insulin dosing regimens to achieve strict glycaemic control in patients with acute ischaemic stroke
    T M Vriesendorp
    Department of Internal Medicine, Academic Medical Centre, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
    J Neurol Neurosurg Psychiatry 80:1040-3. 2009
  3. ncbi Changing the glucose cut-off values that define hypoglycaemia has a major effect on reported frequencies of hypoglycaemia
    S G H A Swinnen
    Department of Internal Medicine, Academic Medical Centre, AZ, Amsterdam, The Netherlands
    Diabetologia 52:38-41. 2009
  4. ncbi Continuation versus discontinuation of insulin secretagogues when initiating insulin in type 2 diabetes
    S G Swinnen
    Department of Internal Medicine, Academic Medical Centre, Amsterdam, The Netherlands
    Diabetes Obes Metab 12:923-5. 2010
  5. ncbi Effect of metformin on glycaemic control in type 2 diabetes in daily practice: a retrospective study
    A M Stades
    Department of Internal Medicine, Diakonessenhuis, Utrecht, The Netherlands
    Neth J Med 56:86-90. 2000
  6. ncbi The influence of aspirin dose and glycemic control on platelet inhibition in patients with type 2 diabetes mellitus
    B A Lemkes
    Department of Internal Medicine, Academic Medical Center, Amsterdam, The Netherlands
    J Thromb Haemost 10:639-46. 2012
  7. ncbi Perturbation of hyaluronan metabolism predisposes patients with type 1 diabetes mellitus to atherosclerosis
    M Nieuwdorp
    Department of Internal Medicine, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
    Diabetologia 50:1288-93. 2007
  8. ncbi The interpretation of glucose clamp studies of long-acting insulin analogues: from physiology to marketing and back
    S G H A Swinnen
    Department of Internal Medicine, Academic Medical Centre, Meibergdreef 9, Amsterdam, The Netherlands
    Diabetologia 51:1790-5. 2008
  9. ncbi Hyperglycemia: a prothrombotic factor?
    B A Lemkes
    Department of Internal Medicine, Academic Medical Centre, Amsterdam, The Netherlands
    J Thromb Haemost 8:1663-9. 2010
  10. ncbi The use of two continuous glucose sensors during and after surgery
    T M Vriesendorp
    Department of Internal Medicine, Academic Medical Center, Amsterdam, The Netherlands
    Diabetes Technol Ther 7:315-22. 2005

Detail Information

Publications10

  1. ncbi Reduced frequency of severe hypoglycemia and coma in well-controlled IDDM patients treated with insulin lispro. The Benelux-UK Insulin Lispro Study Group
    F Holleman
    Department of Internal Medicine, Diakonessenhuis, Utrecht, The Netherlands
    Diabetes Care 20:1827-32. 1997
    ..This study evaluated the effects of insulin lispro on glycemic control and hypoglycemia rates in well-controlled IDDM patients...
  2. ncbi Efficacy and safety of two 5 day insulin dosing regimens to achieve strict glycaemic control in patients with acute ischaemic stroke
    T M Vriesendorp
    Department of Internal Medicine, Academic Medical Centre, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
    J Neurol Neurosurg Psychiatry 80:1040-3. 2009
    ..The question is how to achieve this prolonged strict glycaemic control. In this study, the efficacy and safety of two regimens with different basal to meal related insulin ratio are described...
  3. ncbi Changing the glucose cut-off values that define hypoglycaemia has a major effect on reported frequencies of hypoglycaemia
    S G H A Swinnen
    Department of Internal Medicine, Academic Medical Centre, AZ, Amsterdam, The Netherlands
    Diabetologia 52:38-41. 2009
    ..The aim of this analysis was to quantify the relationship between the frequency of hypoglycaemia and various glucose cut-off points for the definition of hypoglycaemia, within a range of HbA(1c) strata...
  4. ncbi Continuation versus discontinuation of insulin secretagogues when initiating insulin in type 2 diabetes
    S G Swinnen
    Department of Internal Medicine, Academic Medical Centre, Amsterdam, The Netherlands
    Diabetes Obes Metab 12:923-5. 2010
    ..In conclusion, in type 2 diabetic patients starting basal insulin analogue therapy, continuing both metformin and secretagogues results in more hypoglycaemia and weight gain and lower insulin doses than only maintaining metformin...
  5. ncbi Effect of metformin on glycaemic control in type 2 diabetes in daily practice: a retrospective study
    A M Stades
    Department of Internal Medicine, Diakonessenhuis, Utrecht, The Netherlands
    Neth J Med 56:86-90. 2000
    ..Recently the UKPDS study revealed the potency of metformin therapy in obese type 2 diabetic patients. A retrospective study was performed to assess the efficacy of metformin therapy in improving metabolic control in everyday practice...
  6. ncbi The influence of aspirin dose and glycemic control on platelet inhibition in patients with type 2 diabetes mellitus
    B A Lemkes
    Department of Internal Medicine, Academic Medical Center, Amsterdam, The Netherlands
    J Thromb Haemost 10:639-46. 2012
    ..Low-dose aspirin seems to offer no benefit in the primary prevention of cardiovascular disease in type 2 diabetes mellitus (DM2). The anti-platelet effect may be diminished by poor glycemic control or inadequate dosing of aspirin...
  7. ncbi Perturbation of hyaluronan metabolism predisposes patients with type 1 diabetes mellitus to atherosclerosis
    M Nieuwdorp
    Department of Internal Medicine, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
    Diabetologia 50:1288-93. 2007
    ..In the present study, we evaluated the relationship between hyaluronan and hyaluronidase with carotid intima-media thickness (cIMT), an established surrogate marker for cardiovascular disease...
  8. ncbi The interpretation of glucose clamp studies of long-acting insulin analogues: from physiology to marketing and back
    S G H A Swinnen
    Department of Internal Medicine, Academic Medical Centre, Meibergdreef 9, Amsterdam, The Netherlands
    Diabetologia 51:1790-5. 2008
    ....
  9. ncbi Hyperglycemia: a prothrombotic factor?
    B A Lemkes
    Department of Internal Medicine, Academic Medical Centre, Amsterdam, The Netherlands
    J Thromb Haemost 8:1663-9. 2010
    ..Additionally, hyperglycemia is associated with poor clinical outcome of thrombotic events. Whether intensive treatment of hyperglycemia can prevent hypercoagulability and improve clinical outcome remains to be investigated...
  10. ncbi The use of two continuous glucose sensors during and after surgery
    T M Vriesendorp
    Department of Internal Medicine, Academic Medical Center, Amsterdam, The Netherlands
    Diabetes Technol Ther 7:315-22. 2005
    ..We examined whether continuous glucose sensing is feasible and reliable during and after major surgical procedures using two commercially available sensors...